Recent Posts

Big pharma needs a payoff to beat the next superbug

Antibiotics might be the most important medicines we have. They treat everything from dirty cuts to rapidly mutating superbugs that make a stay at a hospital an increasingly scary proposition. With new strains of drug-resistant and potentially deadly bacteria continuing to emerge, it’s essential from a public-health perspective that the antibiotic pipeline remains robust. But instead, big pharmaceutical companies are ...

Read More »

Mickey Mouse wriggles out of his takeover chains

A tiny subsection in the UK takeover code has shot from the margins to the center. The Takeover Panel prompted more controversy over an arcane rule and its application to the battle for Sky Plc. The rule book’s so-called chain principle determines what happens if a bidder takes control of a publicly traded company by buying a firm that owns ...

Read More »

Chevron’s longtime nemesis hits the end of the road

Corporations are easy to hate. They are big, they are impersonal, and they operate by profit-driven rules that can sometimes seem cruel. When corporations are accused of wrongdoing by a community led by a plucky plaintiffs lawyer, there is a natural tendency to believe the latter over the former. Chevron Corp, which is ranked 13th on the Fortune 500 and ...

Read More »
Send this to a friend